Revolutionizing breast cancer treatment: the promise of antibody-drug conjugates.
Year: 2025
Type: article
Source: PubMed
Authors: Samer Alkassis, John A Glaspy, Aditya Bardia
Institution: University of California, Los Angeles
Language: English
Topic: HER2/EGFR in Cancer Research
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4412726795